Claritev Corporation
CTEV
NYSE·Healthcare·Medical - Healthcare Information Services·Mkt cap $655.1M
$38.43
▼ -1.69%
P/E
-2.26
Mkt Cap
$655.1M
52-Wk Range
$11.50–$74.07
52-Week Range
$11.50 - $74.07
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 46.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Proprietary data analytics algorithms detecting claims overcharges and cost inefficiencies
- Extensive contracted provider network with negotiated discounts across the U.S.
- Integrated platform combining payment integrity, network management, and predictive analytics
- 44+ years of healthcare industry expertise and established relationships with major payers
- Advanced data science capabilities for benefit plan optimization and clinical outcome improvement
Bear Case
1 risk
- Low volatility (beta 0.8).
Growth
Stable outlook
Rising healthcare costs driving demand for cost management and claims accuracy solutions
Value
Deep value opportunity - significant discount to Healthcare IT & Services peers
Momentum
Hot
+42.0% over 3m
Quality
Strong
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying CTEV right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 6, 2026
AUG 7, 2026
Reported EPS of -$3.49 vs -$4.12 consensus (+15.3% surprise). Revenue of $257.5M vs $244.8M expected (+5.2%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+15.3%
Revenue trend · last 8Q
—
-5%
-1%
+3%
+7%
+6%
+6%
+7%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$230.5M
$232.1M
$231.3M
$241.6M
$246.0M
$246.6M
$244.7M
$257.5M
Margins · last 8Q
Gross
-25.1%
Operating
9.1%
Profit
-23.0%
Wall Street consensus
4 analysts · 75% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
75%
Hold
25%
Sell
0%
Median Price Target
—
Latest: Barclays · Aug 20, 2026
vs Industry
How CTEV stacks vs Medical - Healthcare Information Services
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related